1. Home
  2. LYRA vs NVFY Comparison

LYRA vs NVFY Comparison

Compare LYRA & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • NVFY
  • Stock Information
  • Founded
  • LYRA 2005
  • NVFY 2003
  • Country
  • LYRA United States
  • NVFY United States
  • Employees
  • LYRA N/A
  • NVFY N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • NVFY Home Furnishings
  • Sector
  • LYRA Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • LYRA Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • LYRA 5.8M
  • NVFY 14.3M
  • IPO Year
  • LYRA 2020
  • NVFY N/A
  • Fundamental
  • Price
  • LYRA $24.28
  • NVFY $1.22
  • Analyst Decision
  • LYRA Buy
  • NVFY
  • Analyst Count
  • LYRA 2
  • NVFY 0
  • Target Price
  • LYRA $100.00
  • NVFY N/A
  • AVG Volume (30 Days)
  • LYRA 1.9M
  • NVFY 36.5K
  • Earning Date
  • LYRA 05-06-2025
  • NVFY 05-15-2025
  • Dividend Yield
  • LYRA N/A
  • NVFY N/A
  • EPS Growth
  • LYRA N/A
  • NVFY N/A
  • EPS
  • LYRA N/A
  • NVFY N/A
  • Revenue
  • LYRA $1,185,000.00
  • NVFY $9,946,300.00
  • Revenue This Year
  • LYRA N/A
  • NVFY N/A
  • Revenue Next Year
  • LYRA $1,286.17
  • NVFY N/A
  • P/E Ratio
  • LYRA N/A
  • NVFY N/A
  • Revenue Growth
  • LYRA N/A
  • NVFY N/A
  • 52 Week Low
  • LYRA $3.81
  • NVFY $0.39
  • 52 Week High
  • LYRA $37.50
  • NVFY $2.08
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 76.38
  • NVFY 55.19
  • Support Level
  • LYRA $22.22
  • NVFY $0.91
  • Resistance Level
  • LYRA $27.42
  • NVFY $1.22
  • Average True Range (ATR)
  • LYRA 4.12
  • NVFY 0.19
  • MACD
  • LYRA 2.36
  • NVFY -0.03
  • Stochastic Oscillator
  • LYRA 60.76
  • NVFY 40.79

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: